| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A case of malignant peritoneal mesothelioma as a rare cause of autoimmune haemolytic anaemia
|
Huppatz, I. Whybrow
|
|
|
42 |
S1 |
p. 58-59
|
article
|
| 2 |
A case report of RAS-associated autoimmune lymphoproliferative disorder
|
Coskun, C.
|
|
|
42 |
S1 |
p. 28-29
|
article
|
| 3 |
Access to cancer medicines and targeted therapies in developing countries
|
Aziz, Zeba
|
|
|
42 |
S1 |
p. 6
|
article
|
| 4 |
Acquired aplastic anemia in childhood: single-center experience
|
Bilici, M.
|
|
|
42 |
S1 |
p. 69
|
article
|
| 5 |
Acute brucellosis presenting as leukocytoclastic vasculitis
|
Ekinci, O.
|
|
|
42 |
S1 |
p. 60
|
article
|
| 6 |
Acute cerebellar syndrome after high dose cytosine arabinoside treatment: case report
|
Yilmaz, F.
|
|
|
42 |
S1 |
p. 36
|
article
|
| 7 |
Acute ischemic stroke presentation of otherwise asymptomatic covid-19 patient
|
Aksoy, E.
|
|
|
42 |
S1 |
p. 46
|
article
|
| 8 |
Acute lymphoblastic leukemia in the context of constitutional mismatch repair deficiency syndrome: a case report
|
Kacar, D.
|
|
|
42 |
S1 |
p. 74
|
article
|
| 9 |
Acute lymphoblastic leukemia with ebv infection and multiple chromosomal abnormalities in a child
|
Kacar, D.
|
|
|
42 |
S1 |
p. 73
|
article
|
| 10 |
Acute phase reactants in chronic inflammation leading to secondary myelofibrosis in polycythemia vera and essential thrombocytosis
|
Aladag, E.
|
|
|
42 |
S1 |
p. 42
|
article
|
| 11 |
A girl with SAMD9L mutation presenting with pancytopenia, immunodeficiency and myelodsyplasia
|
Gokcebay, D. Gurlek
|
|
|
42 |
S1 |
p. 29-30
|
article
|
| 12 |
Alk (−) anaplastic large cell lymphoma diagnosed by tongue root biopsy: case report
|
Yilmaz, F.
|
|
|
42 |
S1 |
p. 50
|
article
|
| 13 |
Analysis of demographic and clinical characteristics of primary myelofibrosis and post-polycythemia vera/essential thrombocythemia myelofibrosis patients
|
Akyol, P.
|
|
|
42 |
S1 |
p. 19
|
article
|
| 14 |
A novel microrna signature with clinical significance in multiple myeloma
|
Papanota, A.
|
|
|
42 |
S1 |
p. 23-24
|
article
|
| 15 |
Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian cancer: a rare case report
|
Ilhan, Y.
|
|
|
42 |
S1 |
p. 33
|
article
|
| 16 |
An unusual case report: myeloid sarcoma presented with appendicitis
|
Yilmaz, F.
|
|
|
42 |
S1 |
p. 36-37
|
article
|
| 17 |
A rare case: coexistence of small cell lung cancer and chronic lymphocytic leukemia
|
Tıglıoglu, M.
|
|
|
42 |
S1 |
p. 40
|
article
|
| 18 |
A rare subtype of poems syndrome: IGG4 subtype
|
Hindilerden, F.
|
|
|
42 |
S1 |
p. 53
|
article
|
| 19 |
A rare variant of dyskeratosis congenita: RTEL1 defect
|
Coskun, C.
|
|
|
42 |
S1 |
p. 68-69
|
article
|
| 20 |
Are the hemoglobin values different after sex-mismatched allogeneic stem cell transplantation?
|
Guner, S. Izmir
|
|
|
42 |
S1 |
p. 64-65
|
article
|
| 21 |
Are there really cancer stem cells and how do they operate?
|
Gale, Robert
|
|
|
42 |
S1 |
p. 10
|
article
|
| 22 |
A signet ring cell carcinoma presented as refractory acquired thrombotic thrombocytopenic purpura
|
Malkan, U.
|
|
|
42 |
S1 |
p. 66
|
article
|
| 23 |
A study of hematological disease prevalence in covid-19 pandemic: a single center experience
|
Gursoy, V.
|
|
|
42 |
S1 |
p. 58
|
article
|
| 24 |
Bendamustine-bortezomib-dexamethasone (BVD) in heavily pretreated multiple myeloma: old/new in novel agents’ era
|
Cerchione, C.
|
|
|
42 |
S1 |
p. 22
|
article
|
| 25 |
Blinatumomab therapy in a relapsed acute lymphoblastic leukemia with isolated radius involvement following allogeneic bone marrow transplant: a case report
|
Açar, İbrahim Halil
|
|
|
42 |
S1 |
p. 18
|
article
|
| 26 |
Bone marrow failure
|
Calado, Rodrigo T.
|
|
|
42 |
S1 |
p. 5
|
article
|
| 27 |
Bone marrow involvement in non-small cell lung cancer
|
Chulkova, S.
|
|
|
42 |
S1 |
p. 32
|
article
|
| 28 |
Bone mineral density and bone resorption in the acute leukemia during childhood
|
Akarsu, S.
|
|
|
42 |
S1 |
p. 29
|
article
|
| 29 |
Candida guillermondii onychomycosis involving fingernails in a breast cancer patient under decetaxel chemothrapy
|
Merad, Y.
|
|
|
42 |
S1 |
p. 77
|
article
|
| 30 |
Can sarcopenia be a risk factor for bleomycin toxicity?
|
Koyuncu, M.
|
|
|
42 |
S1 |
p. 21-22
|
article
|
| 31 |
Caplacizumab induces fast and durable platelet count responses with improved time to complete remission and recurrence-free survival in patients with acquired thrombotic thrombocytopenic purpura
|
Kaynar, L.
|
|
|
42 |
S1 |
p. 62-63
|
article
|
| 32 |
Cardiovascular risk reduction in chronic myeloid leukemia patients treated with the tyrosine kinase inhibitors
|
Lopina, N.
|
|
|
42 |
S1 |
p. 18-19
|
article
|
| 33 |
Carfilzomib-lenalidomide-dexamethasone in the management of lenalidomide-refractory multiple myeloma
|
Cerchione, C.
|
|
|
42 |
S1 |
p. 55-56
|
article
|
| 34 |
CAR T-cell in children all
|
Saglio, Francesco
|
|
|
42 |
S1 |
p. 7
|
article
|
| 35 |
Case report: acute lymphoblastic leukemia with bone involvement
|
Yavaşoglu, F.
|
|
|
42 |
S1 |
p. 38
|
article
|
| 36 |
Challenges in treating solid tumors in developing countries
|
Jabbar, Adnan Abdul
|
|
|
42 |
S1 |
p. 10-11
|
article
|
| 37 |
Chemotherapy delivering port-a-cath migration into the heart: a case report
|
Omar, A.
|
|
|
42 |
S1 |
p. 57
|
article
|
| 38 |
Chronic lymphocytic leukemia presenting as pulmonary involvement in an elderly patient: a case report
|
Ekinci, O.
|
|
|
42 |
S1 |
p. 38-39
|
article
|
| 39 |
Clinical and anamnestic signs of hypercoagulation in patients with β-thalassemia
|
Alieva, N.
|
|
|
42 |
S1 |
p. 44-45
|
article
|
| 40 |
Comparison of 68ga-psma and 18f-fdg pet/ct uptake in different lymphoma
|
Souza, S.
|
|
|
42 |
S1 |
p. 48
|
article
|
| 41 |
Comparison of single and double autologous stem cell transplantation in multiple myeloma patients
|
Malkan, U.
|
|
|
42 |
S1 |
p. 64
|
article
|
| 42 |
Concomitant essential thrombocythemia and mature B-lymphoproliferative disorder in a patient
|
Butt, A.
|
|
|
42 |
S1 |
p. 41-42
|
article
|
| 43 |
COVID-19 infection in cancer patients: a systematic review and meta-analysis with emphasizing the risk and prognosis stratification
|
Elgohary, G.
|
|
|
42 |
S1 |
p. 24-25
|
article
|
| 44 |
Current therapy for indolent lymphomas
|
Amarante, Guilherme Duffles
|
|
|
42 |
S1 |
p. 3-5
|
article
|
| 45 |
Development of novel therapies in MDS
|
Mitani, Kinuko
|
|
|
42 |
S1 |
p. 1
|
article
|
| 46 |
Disease and clinical characteristics of patients with chronic myeloproliferative neoplasms: 11-year single center experience
|
Akyol, P.
|
|
|
42 |
S1 |
p. 43
|
article
|
| 47 |
Effect of helicobacter pylori infection on the first-line treatment outcomes in patients with immune thrombocytopenic purpura
|
Ekinci, O.
|
|
|
42 |
S1 |
p. 61
|
article
|
| 48 |
Efficacy and safety of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment: results of the phase 2 dare study
|
Terpos, E.
|
|
|
42 |
S1 |
p. 22-23
|
article
|
| 49 |
Eltrombopag for thrombocytopenia following pediatric allogeneic hematopoietic stem cell transplantation
|
Akyay, A.
|
|
|
42 |
S1 |
p. 31
|
article
|
| 50 |
Epidemiological spectrum and diagnosis patterns of hematological malignancies in the republic of moldova
|
Musteata, V.
|
|
|
42 |
S1 |
p. 39-40
|
article
|
| 51 |
Erdheim–Chester disease: a single center experience
|
Erkek, E. Turan
|
|
|
42 |
S1 |
p. 59-60
|
article
|
| 52 |
Essential molecular characterization of AML patients
|
Yilmaz, Mehmet
|
|
|
42 |
S1 |
p. 12-13
|
article
|
| 53 |
Exosomes in heme malignancies and pre-cancerous states
|
Kusec, Rajko
|
|
|
42 |
S1 |
p. 16
|
article
|
| 54 |
Experience of istanbul faculty of medicine bone marrow bank: periodical activity documentation
|
Oguz, F.
|
|
|
42 |
S1 |
p. 65
|
article
|
| 55 |
Extranodal marginal zone lymphoma of the ocular adnexa
|
Gül, A.
|
|
|
42 |
S1 |
p. 50
|
article
|
| 56 |
Ex vivo activation of pleural T cells in pleural malignancies
|
Donnenberg, Vera S.
|
|
|
42 |
S1 |
p. 9-10
|
article
|
| 57 |
Factor XIII deficiency case with posttravmatic subcutaneous bleeding
|
Aras, M. Reis
|
|
|
42 |
S1 |
p. 45
|
article
|
| 58 |
Frequency of brucellosis and hepatitis b virus seropositivity in patients with chronic lymphocytic leukemia
|
Ekinci, O.
|
|
|
42 |
S1 |
p. 39
|
article
|
| 59 |
Gastroenteropancreatic neuroendocrine carcinoma: single center experience
|
Sakin, A.
|
|
|
42 |
S1 |
p. 33-34
|
article
|
| 60 |
Health-related quality of life for children with leukemia: child and parental perceptions
|
Ocak, E.
|
|
|
42 |
S1 |
p. 67
|
article
|
| 61 |
Hematological parameters and peripheral blood morphologic abnormalities in children with COVID-19
|
Yarali, N.
|
|
|
42 |
S1 |
p. 27
|
article
|
| 62 |
Hematologic manifestations associated with deficiency of adenosine deaminase 2 and a novel ada2 variant
|
Hanafy, E.
|
|
|
42 |
S1 |
p. 75
|
article
|
| 63 |
Hepcidin level changes in type 2 diabetes
|
Gawaly, A.
|
|
|
42 |
S1 |
p. 57
|
article
|
| 64 |
High-dose methyl prednisolone in veno-occlusive disease
|
Akyay, A.
|
|
|
42 |
S1 |
p. 76
|
article
|
| 65 |
How can we estimate early relapsed follicular lymphoma and how can we treat?
|
Salim, Ozan
|
|
|
42 |
S1 |
p. 15
|
article
|
| 66 |
How clinical networking may be a powerful strategy to face the challenges faced by hematologists treating acute leukemias in the developing world. The experience of the International Consortium on Acute Leukemia (ICAL)
|
Rego, Eduardo M.
|
|
|
42 |
S1 |
p. 13
|
article
|
| 67 |
How to treat and manage covid19 in SCD patients
|
Verdiyeva, N.
|
|
|
42 |
S1 |
p. 76
|
article
|
| 68 |
Hypercalcemia due to concomitant use of all trans retinoic acid and voriconazole
|
Yozgat, A. Koca
|
|
|
42 |
S1 |
p. 73
|
article
|
| 69 |
Hypercalcemia due to the interaction between all trans retinoic acid and posaconazole used for acute promyelocytic leukemia treatment
|
Öztürk, H. Afacan
|
|
|
42 |
S1 |
p. 35
|
article
|
| 70 |
Idiopathic hypereosinophilic syndrome associated pulmonary hypertension in a child
|
Akcabelen, Y.
|
|
|
42 |
S1 |
p. 68
|
article
|
| 71 |
Immune markers are closely related to the remission achievement in childhood acute myeloid leukemia
|
Palladina, A.
|
|
|
42 |
S1 |
p. 70-71
|
article
|
| 72 |
Immunocompromised patients: prevention, diagnosis and therapy of infection
|
Nucci, Marcio
|
|
|
42 |
S1 |
p. 5
|
article
|
| 73 |
Incidence in PH-negative myeloproliferative neoplasms in armenia from 2005 to 2019
|
Sahakyan, L.
|
|
|
42 |
S1 |
p. 19-20
|
article
|
| 74 |
Ir2 leading to complete remission in r/r richter syndrome – a case report
|
Abdullayev, Emin
|
|
|
42 |
S1 |
p. 47
|
article
|
| 75 |
Isatuximab plus carfilzomib and dexamethasone vs. carfilzomib and dexamethasone in relapsed/refractory multiple myeloma (ikema): interim analysis of a phase 3, randomized, open-label study
|
Turgut, M.
|
|
|
42 |
S1 |
p. 51-52
|
article
|
| 76 |
Isolated extramedullary relapse after hematopoietic stem cell transplantation
|
Guzelkucuk, Z.
|
|
|
42 |
S1 |
p. 77
|
article
|
| 77 |
Isolated myeloid sarcoma causing obstructive jaundice in duodenal ampulla: a very rare case
|
Ekinci, Ömer
|
|
|
42 |
S1 |
p. 17
|
article
|
| 78 |
Isolated primary spinal mucosa-associated lymphoid tissue (malt) lymphoma: a rare case report
|
Ekinci, O.
|
|
|
42 |
S1 |
p. 46-47
|
article
|
| 79 |
Klippel–Trenaunay syndrome associated with chronic myeloid leukemia
|
Coskun, C.
|
|
|
42 |
S1 |
p. 71
|
article
|
| 80 |
Literature review: the year in apheresis – what is new?
|
Schwartz, Joseph
|
|
|
42 |
S1 |
p. 12
|
article
|
| 81 |
Long-term results of allogeneic peripheral blood hematopoietic stem cell transplantation for severe aplastic anemia
|
Aladag, E.
|
|
|
42 |
S1 |
p. 27
|
article
|
| 82 |
Lymphoblastyc lymphoma/leukemia: a single center experience
|
Antipova, Alina
|
|
|
42 |
S1 |
p. 11
|
article
|
| 83 |
Minimal residual disease detection in multiple myeloma: methods and prognostic significance
|
Terpos, Evangelos
|
|
|
42 |
S1 |
p. 2
|
article
|
| 84 |
Monoclonal gammopathy of undertemined significance and solitary plasmacytoma: progression factors in population of gomel region in belarus
|
Kozich, Z.
|
|
|
42 |
S1 |
p. 53-54
|
article
|
| 85 |
Multiple relapsed acute lymphoblastic leukemia with t(9;13) in a child
|
Gokcebay, D. Gurlek
|
|
|
42 |
S1 |
p. 72
|
article
|
| 86 |
New drugs for low grade lymphoproliferative diseases
|
Symeonidis, Argiris
|
|
|
42 |
S1 |
p. 14-15
|
article
|
| 87 |
Novel approaches to the treatment of polycythemia vera
|
Ellis, Martin H.
|
|
|
42 |
S1 |
p. 13-14
|
article
|
| 88 |
Occurence of acute myeloid leukemia after primary hepatic carcinoma in a patient who had liver transplantation
|
Coskun, C.
|
|
|
42 |
S1 |
p. 72-73
|
article
|
| 89 |
Paroxysmal nocturnal hemoglobinuria pnh
|
Hamed, Hanan
|
|
|
42 |
S1 |
p. 5-6
|
article
|
| 90 |
Peripheral blood immune profiling of multiple myeloma patients at diagnosis: correlations with circulating plasma cells
|
Papadimitriou, K.
|
|
|
42 |
S1 |
p. 24
|
article
|
| 91 |
Ph-positive and ph-like all: how can we further improve?
|
Foà, Robin
|
|
|
42 |
S1 |
p. 6-7
|
article
|
| 92 |
Poems syndrome: a “multifaceted” entity of plasma cell disorder
|
Sevoyan, D.
|
|
|
42 |
S1 |
p. 54
|
article
|
| 93 |
Polatuzumab based chemoimmunotherapy showing complete response in a patient of r/r diffuse large b-cell lymphoma
|
Atas, U.
|
|
|
42 |
S1 |
p. 51
|
article
|
| 94 |
Polycythemia vera: updates in diagnosis and treatment outcomes
|
Musteata, L.
|
|
|
42 |
S1 |
p. 42-43
|
article
|
| 95 |
Pomalidomide-dexamethasone in the management of heavily pretreated multiple myeloma
|
Cerchione, C.
|
|
|
42 |
S1 |
p. 55
|
article
|
| 96 |
Postdural puncture superior sagittal sinus thrombosis during remission induction therapy for acute lymphoblastic leukemia
|
Ozturkmen, A.
|
|
|
42 |
S1 |
p. 37
|
article
|
| 97 |
Potential risk of subclinical iron deficiency anemia in misinterpretation of glycosylated hemoglobin a1c (hba1c): a case report
|
Bakr, S.
|
|
|
42 |
S1 |
p. 74
|
article
|
| 98 |
Pretreatment neutrophile lymphocyte ratio (NLR) may have a prognostic role in patients receiving pemetrexed treatment for advanced stage non small cell lung adenocarcinoma
|
Seber, S.
|
|
|
42 |
S1 |
p. 78
|
article
|
| 99 |
Primary spinal extramedullary diffuse large B-cell lymphoma presenting with initial spinal cord compression: a case report
|
Ekinci, O.
|
|
|
42 |
S1 |
p. 47-48
|
article
|
| 100 |
Prognostic value of pre-treatment neutrophil-lymphocyte and platelet-lymphocyte ratio in diffuse large B-cell lymphoma: a single-center experience
|
Dagci, G.
|
|
|
42 |
S1 |
p. 48-49
|
article
|
| 101 |
Pyruvate kinase deficiency misdiagnosed as congenital dyserythropoietic anemia type i
|
Yozgat, A. Koca
|
|
|
42 |
S1 |
p. 75-76
|
article
|
| 102 |
Rare infectious agents in children with hematological disease
|
Akcabelen, Y.
|
|
|
42 |
S1 |
p. 67-68
|
article
|
| 103 |
Reactive lymphocytes in blood film of a covid-19 iraqi patient: a case report
|
Al-Ani, A.
|
|
|
42 |
S1 |
p. 57-58
|
article
|
| 104 |
Real experience of brentuximab vedotin for cutaneous T cell lymphomas
|
Karadag, F. Keklik
|
|
|
42 |
S1 |
p. 20-21
|
article
|
| 105 |
Relapsed and refractory classical Hodgkin lymphoma immunotherapy
|
Lepik, Kirill
|
|
|
42 |
S1 |
p. 11-12
|
article
|
| 106 |
Relapse of multiple myeloma presenting as extramedullary plasmacytoma surrounding the aorta: a rare case report
|
Ekinci, O.
|
|
|
42 |
S1 |
p. 52
|
article
|
| 107 |
Retrospective analysis of all patients single center experience
|
Kelkitli, E.
|
|
|
42 |
S1 |
p. 37-38
|
article
|
| 108 |
Risk factors and outcomes related to intensive care unit admission of children with hematological and solid organ malignancies: single-center experience
|
Kaya, C.
|
|
|
42 |
S1 |
p. 28
|
article
|
| 109 |
Risk scores and risk factors in CML, are they helpful?
|
Sacha, Tomasz
|
|
|
42 |
S1 |
p. 2
|
article
|
| 110 |
Safety of caplacizumab in patients without documented severe adamts13 deficiency during the hercules study
|
Besisik, S.
|
|
|
42 |
S1 |
p. 62
|
article
|
| 111 |
Secondary acute leukemia evolving from myeloproliferative neoplasm (MPN)
|
Mughal, Tariq
|
|
|
42 |
S1 |
p. 8-9
|
article
|
| 112 |
Serum & salivary ferritin levels in iron deficiency anemia is there is a difference?
|
Gawaly, A.
|
|
|
42 |
S1 |
p. 56
|
article
|
| 113 |
Speaker Biographies
|
|
|
|
42 |
S1 |
p. v-xv
|
article
|
| 114 |
Stevens–Johnson syndrome secondary to rituximab administration in a chronic lymphocytic leukemia patient
|
Tomacinschii, V.
|
|
|
42 |
S1 |
p. 40-41
|
article
|
| 115 |
Story of success of haploidentical hematopoietic stem cell transplantation in aplastic anemia: a systematic review and meta-analysis of clinical outcome and risk assessment
|
Elgohary, G.
|
|
|
42 |
S1 |
p. 26-27
|
article
|
| 116 |
Study of JAK2V617F gene allele burden in polycythemia vera
|
Khalilova, F.
|
|
|
42 |
S1 |
p. 44
|
article
|
| 117 |
Systemic inflammatory markers as predictors of response to chemoradiotherapy in rectal cancer
|
Seber, S.
|
|
|
42 |
S1 |
p. 78
|
article
|
| 118 |
The ASFA therapeutic apheresis guidelines – 8th edition – overview with focus on hematology/oncology indications
|
Dunbar, Nancy M.
|
|
|
42 |
S1 |
p. 12
|
article
|
| 119 |
The cause of very severe trombocytosis: iron deficiency anemia
|
Uzel, V.
|
|
|
42 |
S1 |
p. 70
|
article
|
| 120 |
The course of intracranial bleeding in the patient with immune thrombocytopenia
|
Babayev, M.
|
|
|
42 |
S1 |
p. 69-70
|
article
|
| 121 |
The course of toxic hepatitis at the stage of treatment consolidation acute leukemia in children
|
Babayev, M.
|
|
|
42 |
S1 |
p. 71
|
article
|
| 122 |
The effects of vitamin D deficiency on myocardial deformation and functions in patients with β-thalassemia
|
Yozgat, A. Koca
|
|
|
42 |
S1 |
p. 30
|
article
|
| 123 |
The factors that affect the results of the response to rituximab treatment in ITP patients
|
Beyler, O.
|
|
|
42 |
S1 |
p. 25
|
article
|
| 124 |
The frequency of anemia in the elderly patient population in Van Province, Turkey. A cross-sectional study
|
Ekinci, O.
|
|
|
42 |
S1 |
p. 60-61
|
article
|
| 125 |
The frequency of calreticulin and mpl gene mutations in bcr-abl and jak2 unmutated chronic myeloproliferative neoplasms and its effect on the outcome
|
Tiryaki, T.
|
|
|
42 |
S1 |
p. 43
|
article
|
| 126 |
The importance of next generation sequence in patients with diffuse large B cell lymphoma
|
Bolaman, A.
|
|
|
42 |
S1 |
p. 20
|
article
|
| 127 |
The molecular spectrum of patients with hereditary spherocytosis: a single center experience
|
Coskun, C.
|
|
|
42 |
S1 |
p. 30-31
|
article
|
| 128 |
The new European leukemianet recommendations for treating CML
|
Hehlmann, Rüdiger
|
|
|
42 |
S1 |
p. 9
|
article
|
| 129 |
The prognostic impact of comorbidity, nutritional and performance status on patients with diffuse large B cell lymphoma
|
Saglam, B.
|
|
|
42 |
S1 |
p. 21
|
article
|
| 130 |
The prognostic significance of neutrophil/lymphocyte ratio in patients with terminal cancer
|
Alemdar, M.
|
|
|
42 |
S1 |
p. 32-33
|
article
|
| 131 |
Therapeutic plasma exchange in gastric signet ring cell carcinoma presenting as microangiopathic hemolytic anemia: a rare case report
|
Ekinci, O.
|
|
|
42 |
S1 |
p. 65-66
|
article
|
| 132 |
The relationship of hepcidin, soluble transferrine receptor, growth differentiation factor-15 and anemia in multiple myeloma
|
Onec, B.
|
|
|
42 |
S1 |
p. 56
|
article
|
| 133 |
The role of T helper 22 cells during engraftment at hematopoietic stem cell transplantation
|
Yucel, O.
|
|
|
42 |
S1 |
p. 26
|
article
|
| 134 |
TIM-3/Gal-9 signaling is the molecular target for human myeloid leukemia treatment
|
Akashi, Koichi
|
|
|
42 |
S1 |
p. 1
|
article
|
| 135 |
Transplant in aplastic anemia using combined G-CSF primed blood and bone marrow stem cells – a retrospective analysis
|
Ali, N.
|
|
|
42 |
S1 |
p. 63
|
article
|
| 136 |
Treatment of relapsed, refractory multiple myeloma: focus on new drugs
|
Maiolino, Angelo
|
|
|
42 |
S1 |
p. 2-3
|
article
|
| 137 |
Treatment of sickle cell crises
|
Alkindi, Salam
|
|
|
42 |
S1 |
p. 8
|
article
|
| 138 |
Two diseases in a single lymph node: nodular lymphocyte predominant hodgkin lymphoma and kaposi's sarcoma
|
Erkek, E. Turan
|
|
|
42 |
S1 |
p. 49-50
|
article
|
| 139 |
Update on chimeric antigen receptor – T cells (CAR-T) CD19 therapy: the Sheba experience
|
Nagler, Arnon
|
|
|
42 |
S1 |
p. 7-8
|
article
|
| 140 |
Welcome Address
|
|
|
|
42 |
S1 |
p. ii-iv
|
article
|
| 141 |
Which aggressive B cell lymphoma should not be treated with RCHOP?
|
Gisselbrecht, Christian
|
|
|
42 |
S1 |
p. 15
|
article
|
| 142 |
XIth Eurasian Hematology Oncology
|
|
|
|
42 |
S1 |
p. i
|
article
|
Journal description